摘要
通过对我国上市后药品监管现状与问题进行分析,提出解决问题的对策与建议。
Based on a systematic overview and analyzing of present condition of post market drug surveillance in China, some of existing problems and questions were arose, the suggestions and strategies for resolution of these questions were presented.
出处
《中国药事》
CAS
2007年第11期869-870,共2页
Chinese Pharmaceutical Affairs
关键词
药品
上市后监管
对策
drug
post market surveillance
strategy
